ARQT Stock Predictions

Recent ARQT Stock Price   ARQT Stock Predictions
$8.73 ARQT stock predictions: higher
+89.00%
$16.50
 As of 2024-04-24
Recent ARQT Analyst Ratings Breakdown, Making ARQT Stock Predictions
  Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong buy ratings: 4 4 4 4
Buy ratings: 1 1 1 1
Hold ratings: 1 1 1 1
Sell ratings: 0 0 0 0
Strong sell ratings: 0 0 0 0
Average rating: 1.5 1.5 1.5 1.5
In the last row of the above table, the average rating presented is from 1 to 5 where 1 means Strong Buy and 5 means Strong Sell.

For the ARQT stock predictions from the analysts covering Arcutis Biotherapeutics Inc, we have collected all of the individual ARQT stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 6 different analysts covering ARQT (as reported in data provided by Zacks Investment Research via Quandl.com).

But since ARQT stock predictions may vary widely, another useful metric to consider is the median ARQT stock prediction, which represents the price at which half of the analysts made ARQT stock predictions that were higher and half made ARQT stock predictions that were lower. This makes for a different take on the ARQT stock predictions out there, as compared to average or mean. And that median across all the individual ARQT stock predictions was: $17.0 as of 2024-04-24.

The very highest of the ARQT stock predictions for one year price target was $26.0, while the very lowest of the ARQT stock predictions in the analyst group was $8.0 (with a standard deviation of $6.442). Get the latest Zacks research report on ARQT — FREE


Find out: ARQT next earnings date »



Slideshow Dividend Growth Stocks: 25 Aristocrats
Slideshow 10 Dividend Bargains You Can Buy Cheaper Than Insiders Did



Other stock predictions:
 • SNY Stock Predictions
 • AUPH Stock Predictions
 • PNFP Stock Predictions
 • CRNT Stock Predictions
 • ATO Stock Predictions
 • KIM Stock Predictions
 • VNO Stock Predictions
 • ESLT Stock Predictions
 • BHE Stock Predictions

Name: 
Arcutis Biotherapeutics Inc
Website: 
www.arcutis.com
Sector: 
Drugs & Pharmaceuticals
Quotes delayed 20 minutes
Email EnvelopeFree ARQT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


Strong Buy (3.50 out of 4)
62nd percentile
(ranked higher than approx. 62% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com


 
 

ARQT Stock Predictions | www.TopDividends.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in this site or parent site DividendChannel.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent. Contact Dividend Channel; Meet Our Editorial Staff.